- Home
- Juvenile Nonfiction
- Health & Daily Living
- Multiple Sclerosis - 9781508182832
Multiple Sclerosis - 9781508182832
List Price:
$33.47
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Richard Spilsbury
Format:
Hardcover
Pages:
48
Publisher:
The Rosen Publishing Group, Inc (July 30, 2018)
Language:
English
ISBN-13:
9781508182832
ISBN-10:
1508182833
Weight:
10.88oz
Dimensions:
7.25" x 9.25"
File:
ROSEN-Rosen Master 020924-20240209-1.xml
Folder:
ROSEN
List Price:
$33.47
Series:
Genetic Diseases and Gene Therapies
As low as:
$28.78
Publisher Identifier:
P-ROSEN
Discount Code:
C
Pub Discount:
62
Overview
Multiple sclerosis, a progressive autoimmune disorder that affects the central nervous system, usually develops between the ages of twenty and fifty. This guide to multiple sclerosis describes the difference between the four types of the disease and how sufferers can manage their symptoms through medications such as corticosteroids. Though scientists are unsure what causes MS or how to prevent it from flaring up, readers will learn about new research into the genetic factors of the disease that could lead to new gene therapy treatments.








